1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Herpes Labialis (Oral Herpes) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Herpes Labialis (Oral Herpes) Clinical Trials by Region
2.2.2 Average Enrollment of Herpes Labialis (Oral Herpes) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Herpes Labialis (Oral Herpes) Treatment, 2019

3. Region wise Herpes Labialis (Oral Herpes) Clinical Trials
3.1 Asia Pacific Herpes Labialis (Oral Herpes) Clinical Trials by Country
3.2 Europe Herpes Labialis (Oral Herpes) Clinical Trials by Country
3.3 North America Herpes Labialis (Oral Herpes) Clinical Trials by Country
3.4 Middle East and Africa Herpes Labialis (Oral Herpes) Clinical Trials by Country
3.5 South and Central America Herpes Labialis (Oral Herpes) Clinical Trials by Country

4. Herpes Labialis (Oral Herpes) Clinical Trial Trends
4.1 Start Year wise Herpes Labialis (Oral Herpes) Clinical Trials
4.2 Phase wise Herpes Labialis (Oral Herpes) Clinical Trials
4.3 Trial Status wise Herpes Labialis (Oral Herpes) Clinical Trials
4.4 Trial Type wise Herpes Labialis (Oral Herpes) Clinical Trials

5. Herpes Labialis (Oral Herpes) Average Enrollment Trends
5.1 Average Enrollment in Herpes Labialis (Oral Herpes) Trials by Year
5.2 Average Enrollment in Herpes Labialis (Oral Herpes) Trials by Phase
5.3 Average Enrollment in Herpes Labialis (Oral Herpes) Trials by Status
5.4 Average Enrollment in Herpes Labialis (Oral Herpes) Trials by Type of Trial

6. Companies Participating in Herpes Labialis (Oral Herpes) Clinical Trials
6.1 Herpes Labialis (Oral Herpes) Trials by Sponsor Type
6.2 Herpes Labialis (Oral Herpes) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Herpes Labialis (Oral Herpes) Trials- Phase 1
7.2 Herpes Labialis (Oral Herpes) Trials- Phase 2
7.3 Herpes Labialis (Oral Herpes) Trials- Phase 3
7.4 Herpes Labialis (Oral Herpes) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Herpes Labialis (Oral Herpes) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Figure 7: North America - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Figure 9: Herpes Labialis (Oral Herpes) Clinical Trials by Phase
Figure 10: Herpes Labialis (Oral Herpes) Clinical Trials by Trial Status
Figure 11: Herpes Labialis (Oral Herpes) Clinical Trials by Type
Figure 12: Herpes Labialis (Oral Herpes) Clinical Trials by Sponsor Type
Figure 13: Herpes Labialis (Oral Herpes) Clinical Trials by Leading Sponsors
Figure 14: Herpes Labialis (Oral Herpes) Average Enrollment by Phase
Figure 15: Herpes Labialis (Oral Herpes) Average Enrollment by Trial Status
Figure 16: Herpes Labialis (Oral Herpes) Average Enrollment by Type
Figure 17: Herpes Labialis (Oral Herpes)- Average Enrolment by Type of Sponsors
Figure 18: Herpes Labialis (Oral Herpes)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Herpes Labialis (Oral Herpes) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Table 5: Europe - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Table 7: North America - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Herpes Labialis (Oral Herpes) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Herpes Labialis (Oral Herpes) Average Enrollment by Phase
Table 15: Herpes Labialis (Oral Herpes) Average Enrollment by Trial Status
Table 16: Herpes Labialis (Oral Herpes) Average Enrollment by Type
Table 17: Herpes Labialis (Oral Herpes)- Average Enrolment by Type of Sponsors
Table 18: Herpes Labialis (Oral Herpes)- Enrolment by Leading Sponsors

Companies mentioned
Benu Biopharma Inc, DermResearch Inc, Dr. Reddy's Laboratories Ltd, Engelhard Arzneimittel GmbH & Co KG, GlaxoSmithKline Plc, Harras Pharma Curarina GmbH, Medivir AB, NanoBio Corp, Novartis AG, Radiant Research Inc